Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Supplementation of ACBP/DBI for the Experimental Treatment of Anorexia Nervosa

ABSTRACT: Supplementation of ACBP/DBI for the Experimental Treatment of Anorexia Nervosa

PROVIDER: PRJNA996577 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25339416_1.fastq.gz	Fastqsanger.gz
	SRR25339416_2.fastq.gz	Fastqsanger.gz
	SRR25339417_1.fastq.gz	Fastqsanger.gz
	SRR25339417_2.fastq.gz	Fastqsanger.gz
	SRR25339418_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 60

Similar Datasets

Supplementation of ACBP/DBI for the Experimental Treatment of Anorexia Nervosa

Project description:Total liver RNA extracts from adult female mice (8-week-old) subjected to CRS (chronic restraint stress) or CDDP (cisplatin) induced anorexia with or without ACBP/DBI delivery to investigate the impact of ACBP/DBI on anorexia-induced transcriptomic alterations.

2024-07-12 | GSE237766 | GEO

Anorexia Nervosa Genetics Initiative (ANGI)

Project description:Anorexia Nervosa Genetics Initiative (ANGI)

| PRJNA434031 | ENA

Anorexia Nervosa Genetics Initiative (ANGI)

Project description:Anorexia Nervosa Genetics Initiative (ANGI)

| PRJNA434032 | ENA

WTCCC3 Anorexia Nervosa

Project description:As part of the Genetic Consortium for Anorexia Nervosa (GCAN) and Wellcome Trust Case Control Consortium 3 (WTCCC3), we have amassed the largest anorexia nervosa (AN) sample in the world (~4,000). Following the WTCCC3 GWAS, we secured funding from the Klarman Family Foundation to extend the genetic analyses to variants on the exome chip (CoreExome array). This pre-lim relates to carrying out genotyping on the CoreExome array on up to a maximum of 580 new samples.

| EGAS00001000913 | EGA

VNN1 : a new biomarker of anorexia nervosa

Project description:VNN1 : a new biomarker of anorexia nervosa

| PRJNA1030915 | ENA

Identification of adipose tissue metabolic memory of anorexia nervosa

Project description:Anorexia nervosa (AN) is a complex debilitating disease characterized by intense fear of weight gain and excessive exercise. It is the deadliest of any psychiatric disorder with a high rate of recidivism, yet its pathophysiology is unclear. The Activity-Based Anorexia (ABA) paradigm is a widely accepted mouse model of AN that recapitulates hypophagia and hyperactivity despite reduced body weight, however, not the chronicity. Here, we modified the prototypical ABA paradigm to increase the time to lose 25% of baseline body weight from less than 7 days to more than 2 weeks. We used this paradigm to identify persistently altered genes after weight restoration that represent a metabolic memory of under-nutrition and may contribute to AN relapse. We focused on adipose tissue as it was identified as a major location of metabolic memory of over-nutririon. We identified 300 persistently dysregulated genes, including Calm2 and Vps13d, which could be potential global regulators of metabolic memory in both chronic over- and under-nutrition. However, despite being on the opposite spectrum of weight perturbations, the majority of metabolic memory genes of under- and over-nutrition do not overlap, suggestive of the different mechanisms involved in these extreme nutritional statuses.

2023-08-23 | GSE229316 | GEO

The role of gut microbiota in anorexia nervosa

Project description:The role of gut microbiota in anorexia nervosa

| PRJEB38930 | ENA

VNN1 : a new biomarker of anorexia nervosa

Project description:Anorexia nervosa (AN) is a psychiatric disorder with an estimated heritability of around 70%. Although the largest genome-wide association study meta-analysis on AN identified independent loci-conferring risk to the disorder, the molecular mechanisms underlying the genetic basis of AN remains to be elucidated. To explore AN, we ran a transcriptome profiling in peripheral blood mononuclear cells of 15 AN subjects and 15 healthy controls. We validated our mean results in a mouse model of chronic food restriction mimicking several aspects of AN. Through this exploratory study we identified 673 significantly differentially expressed genes in AN. Among these genes, we identified the Vanin-1 (Vnn1) gene that appears to play a major role in the regulation of multiple metabolic pathways. We confirmed an underexpression of Vnn1, especially in the liver, in a mouse model of chronic food restriction. These results indicate that quantitative food restriction affects Vnn1 expression, suggesting that this gene may contribute to the anorexic phenotype in the chronic food restriction mouse model as well as in patients affected by AN. We believe that this report highlights promising candidate genes and gene pathways for AN and reveals Vnn1 as a biomarker that may be used as molecular targets to predict and/or to understand AN.

2023-10-31 | GSE245978 | GEO

Identification of adipose tissue metabolic memory of anorexia nervosa

Project description:Identification of adipose tissue metabolic memory of anorexia nervosa

| PRJNA954004 | ENA

Disrupted intestinal microbiota contributes to the pathogenesis of anorexia nervosa

Project description:Disrupted intestinal microbiota contributes to the pathogenesis of anorexia nervosa

| PRJEB51776 | ENA